Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKBIA | P25963 | 4/20 | 0.77 |
| ▸ | GLI1 | P08151 | 5/20 | 0.50 |
| ▸ | IDH1 | O75874 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Physalin A SCHEMBL15853691 | 1.00 | NFKBIA (0.77) | NFKBIAGLI1IDH1 | |
| SCHEMBL30602779 | 0.87 | NFKBIA (1.00) | NFKBIAGLI1IDH1 | |
| SCHEMBL15853690 | 0.87 | NFKBIA (1.00) | NFKBIAGLI1IDH1 | |
| Physalin O SCHEMBL15853705 | 0.85 | GLI1 (0.59) | NFKBIAGLI1IDH1 | |
| Physalin O SCHEMBL30315268 | 0.85 | GLI1 (0.59) | NFKBIAGLI1IDH1 | |
| Physalin O SCHEMBL15857092 | 0.85 | GLI1 (0.59) | NFKBIAGLI1IDH1 | |
| SCHEMBL15853695 | 0.78 | NFKBIA (0.51) | NFKBIAGLI1IDH1 | |
| SCHEMBL31301129 | 0.77 | GLI1 (0.79) | NFKBIAGLI1IDH1 | |
| SCHEMBL29449471 | 0.73 | GLI1 (0.60) | NFKBIAGLI1IDH1 | |
| SCHEMBL15853698 | 0.73 | GLI1 (0.60) | NFKBIAGLI1IDH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118236370-A | Application of physalin A in preparation of anti-gastric cancer drugs | 辽宁大学 | 2024-06-25 | — | — | CN | claimed |
| CN-117106006-A | Preparation method of Wei Chagu Phytin A and application of Phytin A in preparation of antitumor drugs | 沈阳药科大学 | 2023-11-24 | — | — | CN | claimed |
| CN-115452964-B | UPLC characteristic spectrum construction method and quality control method of calyx seu fructus physalis | 华润三九现代中药制药有限公司 | 2023-07-25 | — | — | CN | claimed |
| CN-113750157-B | Preparation method of calyx seu fructus physalis extract, calyx seu fructus physalis extract and application thereof | 中国药科大学 | 2022-07-29 | — | — | CN | claimed |
| CN-117106006-B | Preparation method of Wei Chagu physalin A and application of Wei Chagu physalin A in preparation of antitumor drugs | 沈阳药科大学 | 2025-08-29 | — | — | CN | disclosed |
| CN-117106006-B | Preparation method of Wei Chagu physalin A and application of Wei Chagu physalin A in preparation of antitumor drugs | 沈阳药科大学 | 2025-08-29 | — | — | CN | disclosed |
| CN-119386095-A | Withanolides active component in calyx seu fructus physalis, and extraction method and application thereof | 山东大学 | 2025-02-07 | — | — | CN | disclosed |
| CN-118754893-A | Method for separating and preparing coarse extract of calyx seu fructus physalis and obtaining effective components by liquid chromatography-mass spectrometry | 辽宁大学 | 2024-10-11 | — | — | CN | disclosed |
| CN-118754893-A | Method for separating and preparing coarse extract of calyx seu fructus physalis and obtaining effective components by liquid chromatography-mass spectrometry | 辽宁大学 | 2024-10-11 | — | — | CN | disclosed |
| CN-118236370-A | Application of physalin A in preparation of anti-gastric cancer drugs | 辽宁大学 | 2024-06-25 | — | — | CN | disclosed |
| CN-118236370-A | Application of physalin A in preparation of anti-gastric cancer drugs | 辽宁大学 | 2024-06-25 | — | — | CN | disclosed |
| CN-118236370-A | Application of physalin A in preparation of anti-gastric cancer drugs | 辽宁大学 | 2024-06-25 | — | — | CN | disclosed |
| CN-115452964-B | UPLC characteristic spectrum construction method and quality control method of calyx seu fructus physalis | 华润三九现代中药制药有限公司 | 2023-07-25 | — | — | CN | disclosed |
| CN-115452964-A | UPLC characteristic spectrum construction method and quality control method of calyx seu fructus physalis | 华润三九现代中药制药有限公司 | 2022-12-09 | — | — | CN | disclosed |
| CN-115452964-A | UPLC characteristic spectrum construction method and quality control method of calyx seu fructus physalis | 华润三九现代中药制药有限公司 | 2022-12-09 | — | — | CN | disclosed |
| CN-113750157-B | Preparation method of calyx seu fructus physalis extract, calyx seu fructus physalis extract and application thereof | 中国药科大学 | 2022-07-29 | — | — | CN | disclosed |
| CN-113750157-B | Preparation method of calyx seu fructus physalis extract, calyx seu fructus physalis extract and application thereof | 中国药科大学 | 2022-07-29 | — | — | CN | disclosed |
| CN-114634571-A | Humanized CC chemokine receptor 4(CCR4) antibodies and methods of use thereof | 达纳－法伯癌症研究所公司 | 2022-06-17 | — | — | CN | disclosed |
| CN-107849134-B | Methods of mediating cytokine expression with anti-CCR 4 antibodies | 达纳－法伯癌症研究所公司 | 2022-05-03 | — | — | CN | disclosed |
| CN-114181227-A | Method for extracting physalin and method for purifying extracting solution thereof | 佳木斯大学 | 2022-03-15 | — | — | CN | disclosed |